Wallace Hilary J, Fear Mark W, Crowe Margaret M, Martin Lisa J, Wood Fiona M
Burn Injury Research Unit, Faculty of Health and Medial Sciences, University of Western Australia, Perth, Western Australia, Australia.
Burns Service of Western Australia, Fiona Stanley Hospital, Perth, Western Australia, Australia.
Burns. 2017 Sep;43(6):1271-1283. doi: 10.1016/j.burns.2017.03.017. Epub 2017 Apr 15.
This study examined influences on scarring after burn in a prospective study using a defined outcome measure: scar height measured by a modified Vancouver Scar Scale (mVSS). A prospective case-control study was conducted among 616 adult subjects who sustained a burn in Western Australia. Patient factors influencing scar outcome including gender, Fitzpatrick skin type and selected co-morbidities were explored, as well as injury and clinical factors. A logistic regression model for raised scar after burn was developed which achieved an overall correct prediction rate of 81.1%; 74.8% for those with raised scar and 86.0% for those without raised scar. From this study, injury and clinical predictors for raised scar after adjustment for other variables are: increasing %TBSA, greater burn depth as indicated by level of surgical intervention, wound complications and prolonged hospital stay. Intrinsic patient predictors for raised scar in patients with comparable injuries are: young age (≤30 years), female gender and Fitzpatrick skin types 4-6. The strength of association statistics (odds ratios and 95% confidence intervals) reported will be of practical benefit for clinical decision-making and counselling of patients, and plausible biological explanations for the findings support the validity of the results.
通过改良温哥华瘢痕量表(mVSS)测量瘢痕高度,以前瞻性研究的方式探究烧伤后瘢痕形成的影响因素。在西澳大利亚州对616名成年烧伤患者进行了一项前瞻性病例对照研究。研究探讨了影响瘢痕结局的患者因素,包括性别、菲茨帕特里克皮肤类型和选定的合并症,以及损伤和临床因素。建立了一个烧伤后瘢痕增生的逻辑回归模型,其总体正确预测率为81.1%;瘢痕增生患者的预测率为74.8%,无瘢痕增生患者的预测率为86.0%。通过本研究,在对其他变量进行调整后,烧伤后瘢痕增生的损伤和临床预测因素为:烧伤总面积百分比增加、手术干预程度所表明的烧伤深度增加、伤口并发症和住院时间延长。在损伤程度相当的患者中,瘢痕增生的内在患者预测因素为:年轻(≤30岁)、女性以及菲茨帕特里克皮肤类型4 - 6。所报告的关联强度统计数据(比值比和95%置信区间)将对临床决策和患者咨询具有实际益处,并且对研究结果合理的生物学解释支持了结果的有效性。